Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Patients with Multiple Sclerosis in Year 5 After Initiation of Treatment with Cladribine Tablets: Analysis of Longitudinal Prescription Data from Germany

              Author:von der Maßen, Kristina   Kormann, David   Huebschen, Michael   Wagner, Torsten B   Tundia, Namita   Russel-Szymczyk, Monika   

              Session Name:P8: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 1  

              Topic:Multiple Sclerosis  

              Program Number:P8.017  

              Author Institution:Real World Solutions, IQVIA Commercial GmbH & Co. OHG, Frankfurt, Germany, Frankfurt, Germany  Merck Healthcare Germany GmbH, Weiterstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany, Weiterstadt, Germany  EMD Serono, Billerica, MA, USA, Billerica, MA  Merck Sp. z. o.o., Warsaw, Poland, an affiliate of Merck KGaA, Darmstadt, Germany, Warsaw, Poland